Ercros, S.A. (BME:ECR)

Market Cap	311.34M +16.2%
Revenue (ttm)	628.69M -5.9%
Net Income	-53.59M
EPS	-0.59
Shares Out	91.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	106,738
Average Volume	430,429
Open	3.405
Previous Close	3.405
Day's Range	3.395 - 3.430
52-Week Range	2.230 - 3.475
Beta	0.36
RSI	56.05
Earnings Date	Feb 27, 2026

About Ercros

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, caustic potash, caustic soda, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride. The Intermediate Chemical...

• Industry: Chemicals
• Sector: Materials
• Founded: 1817
• Employees: 1,357
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ECR

Financial Performance

In 2025, Ercros's revenue was 628.69 million, a decrease of -5.92% compared to the previous year's 668.22 million. Losses were -53.59 million, 359.7% more than in 2024.